Genetic polymorphism of GSTT1 and GSTM1 and susceptibility to chronic obstructive pulmonary disease (COPD)

Journal of Critical Care

Volumn 24, Issue 3, 2009, Pages

  Faramawy, Mona M ^a   Mohammed, Tasnim O ^a   Hossaini, Aysheh M ^a   Kashem, Reem A ^a   Abu Rahma, Rania M ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

DNA; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE T1;

ADULT; ARTICLE; CASE CONTROL STUDY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA EXTRACTION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HETEROZYGOTE; HIGH RISK POPULATION; HUMAN; HUMAN CELL; LEUKOCYTE; NULL ALLELE; SMOKING;

CASE-CONTROL STUDIES; ELECTROPHORESIS, AGAR GEL; FEMALE; GENOTYPE; GLUTATHIONE TRANSFERASE; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SMOKING;

EID: 67949102168     PISSN: 08839441     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcrc.2009.06.004     Document Type: Article

References (21)

1. Židzik J., Slabá1 E., Joppa P., et al. GSTM1, GSTT1, and EPHX1 genes and chronic obstructive pulmonary disease. Croat Med J 49 (2008) 182-191
2. Ishii T., Matsuse T., Teramoto S., et al. Glutathione S-transferase P1 (GSTP1) polymorphism in patients with chronic obstructive pulmonary disease. Thorax 54 (1999) 693-696
3. Yim J.J., Park G.Y., Lee C.T., et al. Morality patterns (1997) preliminary data, United States. MMWR 46 (1996) 941-948
4. Wood A.M., and Stockley R.A. The genetics of chronic obstructive pulmonary disease. Respir Res 7 (2006) 130-144
5. Cheng S.L., Yu C.J., Chen C.J., et al. Genetic polymorphism of epoxide hydrolase and glutathione S-transferase in COPD. Eur Respir J 23 (2004) 818-824
6. Fletcher C., Peto R., Tinker C., et al. The natural history of chronic bronchitis and emphysema: an eight-year follow-up study of working men in London (1979), Oxford University Press, Oxford 70-105
7. Wu M.C. Study on maximal expiratory flow and volume in Chinese. I. Normal nonsmoking adults. J Formos Med Assoc 80 (1981) 19-29
8. Joseph S., David W.R., Nina I., et al. J. molecular cloning: rapid isolation of genetic polymorphism in cytochrome p450 2E1 and glutathione S-transferase M1, T1, and P1 on susceptibility to esophageal cancer among high-risk individuals in China. Cancer Epidemiol Biomarkers Prev 9 (2002) 551-556
9. Abdel-Rahman S.Z., Anwar W.A., Abdel-Aal, et al. GSTM1 and GSTT1 genes are potential risk modifiers for bladder cancer. Cancer Detect Prev 22 (1998) 129-138
10. Joseph S., and David W.R. Gel electrophoresis of DNA. 3rd ed. vol. 5 (2001), Cold Spring Harbor Laboratory Press, New York 5.14-5.17
11. Devi M.R., Srivastava D.S.L., Mandhani A., et al. Polymorphism of GSTM1 and GSTT1 genes in prostate cancer: a study from north India. Ind J Cancer 41 (2004) 115-119
12. Mannino D.M., and Braman S. The epidemiology and economics of chronic obstructive pulmonary disease. Proc Am Thorac Soc 4 (2007) 502-506
13. Teramoto S. COPD pathogenesis from the viewpoint of risk factors. Intern Med 46 (2007) 77-79
14. Sandford A.J., Joos L., and Pare P.D. Genetic risk factors for chronic obstructive pulmonary disease. Curr Opin Pulm Med 8 (2002) 87-94
15. Doll R., Peto R., Boreham J., et al. Mortality in relation to smoking: 50 years' observations on male British doctors. BMJ 328 (2004) 32
16. Boström C.E., Gerde P.., Hanberg A., et al. Cancer risk assessment, indicators, and guidelines for polycyclic aromatic hydrocarbons in the ambient air. Environ Health Perspect 11 (2002) 451-548
17. Baranova H., Perriot J., Albuisson E., Ivaschenko, et al. Peculiarities of the GSTM1 0/0 genotype in French heavy smokers with various types of chronic bronchitis. Hum Genet 99 (1997) 822-826
18. Cheng S.L., Yu C.J., Chen C.J., et al. Genetic polymorphism of epioxide hydrolase and glutathione S-transferase in COPD. Eur Respir J 23 (2004) 818-824
19. Harrison D.J., Cantlay A.M., and Rae. Frequency of glutathione S-transferase M1 deletion in smokers with emphysema and lung cancer. Hum Exp Toxicol 16 (1997) 356-360
20. He J.Q., Ruan J., Connett J.E., et al. Antioxidant gene polymorphisms and susceptibility to a rapid decline in lung function in smokers. Am J Respir Crit Care Med 166 (2002) 323-328
21. Gaspar P., Moreira J., and Kvitko K. CYP1A1, CYP2E1, GSTM1, GSTT1, GSTP1 and TP53 polymorphisms: do they indicate susceptibility to chronic obstructive pulmonary disease and non-small cell lung cancer. Genet Mol Biol 27 (2004) 1-10